최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biochemical and biophysical research communications, v.528 no.1, 2020년, pp.46 - 53
Shin, Eunju (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology Yuseong-gu) , Jeong, Jong-Gwan (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology Yuseong-gu) , Chung, Hyunmin (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology Yuseong-gu) , Jung, Haiyoung (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology Yuseong-gu) , Park, Charny (Bioinformatics Team, Research Institute, National Cancer Center) , Yoon, Suk Ran (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology Yuseong-gu) , Kim, Tae-Don (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology Yuseong-gu) , Lee, Seung Jin (College of Pharmacy, Chungnam National University) , Choi, Inpyo (Immunotherapy Research Cente) , Noh, Ji-Yoon
Abstract GATA1 is a master transcription factor of megakaryopoiesis and erythropoiesis, and loss-of-function mutation can induce accumulation of megakaryocyte–erythroid progenitors (MEPs) in mice and humans. Accordingly, the murine MEP cell line (termed G1ME2 cells) encoding doxycycline (dox)...
Blood Stachura 107 87 2006 10.1182/blood-2005-07-2740 Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1
J. Clin. Invest. Noh 125 2369 2015 10.1172/JCI77670 Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells
Blood Vyas 93 2867 1999 10.1182/blood.V93.9.2867 Consequences of GATA-1 deficiency in megakaryocytes and platelets
Nature Whyatt 406 519 2000 10.1038/35020086 An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells
Blood Campbell 121 5218 2013 10.1182/blood-2013-03-488080 Analysis of disease-causing GATA1 mutations in murine gene complementation systems
Blood Adv. Hanby 1 1478 2017 10.1182/bloodadvances.2017006726 Platelet dense granules begin to selectively accumulate mepacrine during proplatelet formation
Nat. Genet. Wechsler 32 148 2002 10.1038/ng955 Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
Eur. J. Haematol. Hopfer 88 144 2012 10.1111/j.1600-0609.2011.01715.x Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis
J. Clin. Invest. Gilles 127 1316 2017 10.1172/JCI82905 Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis
Blood Vannucchi 100 1123 2002 10.1182/blood-2002-06-1913 Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice)
Am. J. Pathol. Vannucchi 167 849 2005 10.1016/S0002-9440(10)62056-1 Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis
Mol. Cell Biol. Shimizu 24 10814 2004 10.1128/MCB.24.24.10814-10825.2004 Leukemogenesis caused by incapacitated GATA-1 function
Blood Ghinassi 109 1460 2007 10.1182/blood-2006-07-030726 The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor
Proc. Natl. Acad. Sci. U. S. A. Grass 100 8811 2003 10.1073/pnas.1432147100 GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling
Blood Chou 114 983 2009 10.1182/blood-2009-03-207944 Graded repression of PU. 1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate
Nat. Med. Will 21 1172 2015 10.1038/nm.3936 1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia
Blood Abkowitz 109 5186 2007 10.1182/blood-2006-08-044503 Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones
Stem Cell Res. Sun 9 77 2012 10.1016/j.scr.2012.05.001 Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis
Development Mitjavila-Garcia 129 2003 2002 10.1242/dev.129.8.2003 Expression of CD41 on hematopoietic progenitors derived from embryonic hematopoietic cells
PLoS One Perez 3 e3565 2008 10.1371/journal.pone.0003565 SH2-inositol phosphatase 1 negatively influences early megakaryocyte progenitors
J. Cell Sci. Guerriero 119 744 2006 10.1242/jcs.02784 Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes
Haematologica Raslova 101 1443 2016 10.3324/haematol.2016.153668 A potent stimulator of megakaryopoiesis
Front. Endocrinol. Plo 8 234 2017 10.3389/fendo.2017.00234 Genetic alterations of the Thrombopoietin/MPL/JAK2 Axis impacting megakaryopoiesis
Blood Vainchenker 129 667 2017 10.1182/blood-2016-10-695940 Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
Nature Viale 457 51 2009 10.1038/nature07618 Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
CellStem Cell Hsu 23 700 2018 10.1016/j.stem.2018.10.004 PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy
Nat. Med. Wen 21 1473 2015 10.1038/nm.3995 Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition
PLoS One Currao 8 2013 10.1371/journal.pone.0054723 High doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocytes
J. Cell Mol. Med. Bartalucci 17 1385 2013 10.1111/jcmm.12162 Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.